Breaking News, Promotions & Moves

Carbogen Amcis CEO to Step Down in March

Stephan Fritschi to succeed Pascal Villemagne.

Author Image

By: Charlie Sternberg

Associate Editor

Stephan Fritschi.

Switzerland-based Carbogen Amcis, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, has announced the departure of its current CEO, Pascal Villemagne, and the appointment of his replacement, Stephan Fritschi. After thirteen years with Carbogen Amcis, the last three of which he served as Chief Executive Officer (CEO), Pascal Villemagne has announced his intent to step down. He will remain in his role until March 31, 2025, and facilitate the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters